Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10636620rdf:typepubmed:Citationlld:pubmed
pubmed-article:10636620lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C1527311lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0012472lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0085094lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0387583lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C2004454lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:10636620lifeskim:mentionsumls-concept:C0132515lld:lifeskim
pubmed-article:10636620pubmed:issue1lld:pubmed
pubmed-article:10636620pubmed:dateCreated2000-2-3lld:pubmed
pubmed-article:10636620pubmed:abstractTextRecently, the enzyme cyclooxygenase (COX) has been recognized to exist as constitutive (COX-1) and inducible isoforms (COX-2). In previous studies, drugs that were inhibitors of both COX-1 and COX-2 failed to decrease brain edema formation or improve Neurological Severity Score (NSS) after closed head trauma (CHT), although some did decrease prostaglandin-E2 (PGE2) formation. The present study examined whether or not a specific inhibitor of COX-2 (nimesulide) exerts a beneficial effect after CHT in rats. Halothane-anesthetized rats (n = 8 in each group) were randomly assigned to one of four groups: surgery, no CHT, no drug (group 1); surgery, no CHT, nimesulide 30 mg/kg intraperitoneally (IP) (group 2); surgery, CHT, no drug (group 3); and surgery, CHT, nimesulide 30 mg/kg IP (group 4). NSS was determined at 1 and 24 h, and brain tissue PGE2 concentration and water content were determined after killing at 24 h. Treatment with nimesulide did not improve NSS (NSS at 24 h = 11+/-6 [median +/- range] in group 3 and 12+/-4 in group 4) or edema formation (brain water content at 24 h = 84.3+/-1.8% [mean +/- SD] in group 3 and 83.8+/-1.9% in group 4). However, nimesulide did decrease cortical and hypothalamic PGE2 formation by 41% and 47%, respectively during the first hour of incubation after brain tissue sampling. The authors conclude that although nimesulide does reduce tissue PGE2 formation, it does not exert a beneficial effect on brain tissue edema or functional activity after CHT in rats.lld:pubmed
pubmed-article:10636620pubmed:languageenglld:pubmed
pubmed-article:10636620pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:citationSubsetIMlld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10636620pubmed:statusMEDLINElld:pubmed
pubmed-article:10636620pubmed:monthJanlld:pubmed
pubmed-article:10636620pubmed:issn0898-4921lld:pubmed
pubmed-article:10636620pubmed:authorpubmed-author:RubinMMlld:pubmed
pubmed-article:10636620pubmed:authorpubmed-author:ShapiraYYlld:pubmed
pubmed-article:10636620pubmed:authorpubmed-author:KaplanskiJJlld:pubmed
pubmed-article:10636620pubmed:authorpubmed-author:ArtruA AAAlld:pubmed
pubmed-article:10636620pubmed:authorpubmed-author:TalmorDDlld:pubmed
pubmed-article:10636620pubmed:authorpubmed-author:KoyfmanLLlld:pubmed
pubmed-article:10636620pubmed:issnTypePrintlld:pubmed
pubmed-article:10636620pubmed:volume12lld:pubmed
pubmed-article:10636620pubmed:ownerNLMlld:pubmed
pubmed-article:10636620pubmed:authorsCompleteYlld:pubmed
pubmed-article:10636620pubmed:pagination44-50lld:pubmed
pubmed-article:10636620pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:meshHeadingpubmed-meshheading:10636620...lld:pubmed
pubmed-article:10636620pubmed:year2000lld:pubmed
pubmed-article:10636620pubmed:articleTitleInhibition of cyclooxygenase 2 by nimesulide decreases prostaglandin E2 formation but does not alter brain edema or clinical recovery after closed head injury in rats.lld:pubmed
pubmed-article:10636620pubmed:affiliationDivision of Anesthesiology, Soroka Medical Center, Faculty of Health Science, Ben Gurion University of the Negev, Beer-Sheva, Israel.lld:pubmed
pubmed-article:10636620pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10636620lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10636620lld:pubmed